Jayakumari Nandini Ravikumar, Reghuvaran Anand Chellappan, Rajendran Raji Sasikala, Pillai Vivek Velayudhan, Karunakaran Jayakumar, Sreelatha Harikrishnan Vijayakumar, Gopala Srinivas
Department of Biochemistry, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram 695011, India.
Department of Cardiovascular and Thoracic Surgery, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram 695011, India.
Nitric Oxide. 2014 Dec 1;43:35-44. doi: 10.1016/j.niox.2014.08.002. Epub 2014 Aug 19.
Protein modifications effected by nitric oxide (NO) primarily in conjunction with reactive oxygen species (ROS) include tyrosine nitration, cysteine S-nitrosylation, and glutathionylation. The physiological and pathological relevance of these three modifications is determined by the amino acids on which these modifications occur -cysteine and tyrosine, for instance, ranging from altering structural integrity/catalytic activity of proteins or by altering propensity towards protein degradation. Even though tyrosine nitration is a well-established nitroxidative stress marker, instilled as a footprint of oxygen- and nitrogen-derived oxidants, newer data suggest its wider role in embryonic heart development and substantiate the need to focus on elucidating the underlying mechanisms of reversibility and specificity of tyrosine nitration. S-nitrosylation is a covalent modification in specific cysteine residues of proteins and is suggested as one of the ways in which NO contributes to its ubiquitous signalling. Several sensitive and specific techniques including biotin switch assay and mass spectrometry based analysis make it possible to identify a large number of these modified proteins, and provide a great deal of potential S-nitrosylation sites. The number of studies that have documented nitrated proteins in diabetic heart is relatively much less compared to what has been published in the normal physiology and other cardiac pathologies. Nevertheless, elucidation of nitrated proteome of diabetic heart has revealed the presence of many mitochondrial and cytosolic proteins of functional importance. But, the existence of different models of diabetes and analyses at diverse stages of this disease have impeded scientists from gaining insights that would be essential to understand the cardiac complications during diabetes. This review summarizes NO mediated protein modifications documented in normal and abnormal heart physiology including diabetes.
一氧化氮(NO)主要与活性氧(ROS)共同作用引起的蛋白质修饰包括酪氨酸硝化、半胱氨酸S-亚硝基化和谷胱甘肽化。这三种修饰的生理和病理相关性取决于发生这些修饰的氨基酸——例如半胱氨酸和酪氨酸,范围从改变蛋白质的结构完整性/催化活性或改变蛋白质降解倾向。尽管酪氨酸硝化是一种公认的氮氧化应激标志物,被视为氧衍生和氮衍生氧化剂的印记,但新数据表明其在胚胎心脏发育中具有更广泛的作用,并证实有必要专注于阐明酪氨酸硝化的可逆性和特异性的潜在机制。S-亚硝基化是蛋白质特定半胱氨酸残基的共价修饰,被认为是NO参与其普遍存在的信号传导的方式之一。包括生物素开关试验和基于质谱的分析在内的几种灵敏且特异的技术使得识别大量这些修饰蛋白成为可能,并提供了大量潜在的S-亚硝基化位点。与正常生理学和其他心脏病理学中已发表的研究相比,记录糖尿病心脏中硝化蛋白的研究数量相对较少。然而,对糖尿病心脏硝化蛋白质组的阐明揭示了许多具有功能重要性的线粒体和胞质蛋白的存在。但是,糖尿病不同模型的存在以及在该疾病不同阶段的分析阻碍了科学家获得对于理解糖尿病期间心脏并发症至关重要的见解。本综述总结了在正常和异常心脏生理学(包括糖尿病)中记录的NO介导的蛋白质修饰。